1. Home
  2. STXS

STXS

Stereotaxis Inc.

Logo Stereotaxis Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

Founded: 1990 Country:
United States
United States
Employees: N/A City: ST.LOUIS
Market Cap: 211.9M IPO Year: 2004
Target Price: $4.50 AVG Volume (30 days): 313.3K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.27 EPS Growth: N/A
52 Week Low/High: $1.33 - $3.29 Next Earning Date: 05-07-2024
Revenue: $26,771,000 Revenue Growth: -4.89%
Revenue Growth (this year): 16.59% Revenue Growth (next year): 42.29%

Share on Social Networks: